logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yuichi Tambo

Kanazawa University Hospital
H指数:15
被引数:1,134

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Outcomes and Early Progressive Disease Analysis of Nivolumab and Ipilimumab Combination Therapy in Metastatic NSCLC: LIGHT-NING Study 2.5-year update

真实世界结局和早期进展性疾病分析：纳武利尤单抗联合伊匹木单抗治疗转移性非小细胞肺癌的LIGHT-NING研究2.5年更新

Clinical Lung Cancer
IF3.3
2026-10-130
OAAI
Hisao Imai; Teppei Yamaguchi; Koichi Azuma; Takashi Kijima; Yukihiro Toi; Kazuma Kishi; Kohei Fujita; Haruhiro Saito; Yoshimasa Shiraishi; Junko Tanizaki; Yuta Takashima; Yuichi Tambo; Satoshi Watanabe; Osamu Hataji; Tatsuro Fukuhara; Tomoyuki Ohsugi; Yu Tobishima; Hidehito Horinouchi
Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis

纳武利尤单抗联合伊匹木单抗为基础的治疗在日本转移性非小细胞肺癌患者（肿瘤PD-L1 < 1%）中的合并分析

International Journal of Clinical Oncology
IF2.8
2026-08-110
OA
Makoto Nishio; Hidetoshi Hayashi; Yasushi Goto; Satoshi Ikeda; Toshihide Yokoyama; Hiroshi Tanaka; Yuichi Tambo; Katsuyuki Hotta; Tatsuro Fukuhara; Haruko Daga; Ken Masubuchi; Takekazu Aoyama; Marina Tschaika; Nan Hu; Hideaki Mizutani
Efficacy of ipilimumab plus nivolumab with or without chemotherapy according to baseline tumor size: a multicenter retrospective study

依匹木单抗联合纳武利尤单抗，联合或不联合化疗，根据基线肿瘤大小评估其疗效：一项多中心回顾性研究

Translational Lung Cancer Research
IF3.5
2026-06-300
PRE
Tanaka, Hisashi; Makiguchi, Tomonori; Tozuka, Takehiro; Kawashima, Yosuke; Oba, Tomohiro; Tsugitomi, Ryosuke; Koyama, Junji; Tambo, Yuichi; Ogusu, Shinsuke; Saiki, Masafumi; Gyotoku, Hiroshi; Hasegawa, Tsukasa; Miyauchi, Eisaku; Sonoda, Tomoaki; Saito, Ryota; Nakatomi, Katsumi; Sakatani, Toshio; Kudo, Keita; Tsuchiya-Kawano, Yuko; Nishio, Makoto
Prognostic value of preoperative ctDNA and pathological venous invasion for recurrence in EGFR-mutated non-small cell lung cancer

EGFR突变非小细胞肺癌中术前ctDNA和病理静脉侵犯对复发的预测价值

Lung Cancer
IF4.4
2025-11-040
PRE
Yuya Murase; Hayato Koba; Hideharu Kimura; Isao Matsumoto; Tsukasa Ueda; Shunichi Nomura; Sachiko Arai; Nanao Terada; Liu Yifeng; Shigeki Nanjo; Yuichi Tambo; Takafumi Kobayashi; Satoshi Watanabe; Kenta Yamamura; Noriyuki Ohkura; Miki Abo; Akihiro Nomura; Seiji Yano
A 72-Year-Old Man With Progressive Dyspnea and Diffuse Lung Disease

一位72岁男性，主诉进行性呼吸困难及弥漫性肺部疾病

CHEST
IF8.6
2025-07-080
PRE
Ryo Hara; Satoshi Watanabe; Yuya Murase; Tsukasa Ueda; Atsushi Muto; Kazumasa Kase; Yoshihiro Takeda; Nanao Terada; Hayato Koba; Kenta Yamamura; Shigeki Nanjo; Yuichi Tambo; Noriyuki Ohkura; Miki Abo; Johsuke Hara; Seiji Yano
Five-year efficacy and safety of pembrolizumab as first-line treatment in patients with non-small cell lung cancer with PD-L1 tumor proportion score ≥50 %: A multicenter observational study

帕博利珠单抗作为非小细胞肺癌患者（PD-L1肿瘤比例评分≥50%）一线治疗的五年疗效和安全性：一项多中心观察性研究

LUNG CANCER
IF4.4
2025-03-011
PRE
Tambo, Yuichi; Sone, Takashi; Nishi, Koichi; Shibata, Kazuhiko; Kita, Toshiyuki; Araya, Tomoyuki; Shirasaki, Hiroki; Shimizu, Takahiro; Yoneda, Taro; Matsuoka, Hiroki; Nanjo, Shigeki; Koba, Hayato; Terada, Nanao; Ueda, Tsukasa; Nomura, Shunichi; Murase, Yuya; Yano, Seiji
Comparison of immune checkpoint inhibitor plus chemotherapy or ipilimumab plus nivolumab-based therapy for NSCLC patients with PD-L1 TPS (1-49%): TOPGAN2023-01
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-12-010
PRE
Tanaka, Hisashi; Makiguchi, Tomonori; Tozuka, Takehiro; Kawashima, Yosuke; Oba, Tomohiro; Tsugitomi, Ryosuke; Koyama, Junji; Tambo, Yuichi; Ogusu, Shinsuke; Saiki, Masafumi; Gyotoku, Hiroshi; Hasegawa, Tsukasa; Miyauchi, Eisaku; Sonoda, Tomoaki; Saito, Ryota; Nakatomi, Katsumi; Sakatani, Toshio; Kudo, Keita; Tsuchiya-Kawano, Yuko; Nishio, Makoto
EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer
TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2024-11-010
OAAI
Terada, Nanao; Koba, Hayato; Nanjo, Shigeki; Kimura, Hideharu; Nishiyama, Akihiro; Yoneda, Taro; Takeda, Takayuki; Shirasaki, Hiroki; Nishi, Koichi; Sone, Takashi; Yamada, Tadaaki; Takayama, Koichi; Shibata, Kazuhiko; Matsuoka, Hiroki; Kita, Toshiyuki; Nagata, Kazuhiro; Tambo, Yuichi; Ohkura, Noriyuki; Hara, Johsuke; Kasahara, Kazuo; Kohsaka, Shinji; Mano, Hiroyuki; Yano, Seiji
Promotive clinical effects of pembrolizumab with necitumumab in patients having advanced non-small cell lung cancer with PD-L1 expression of 50% or higher in a phase II study (K-TAIL-202)
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Horiike, Atsushi; Wakui, Hiroshi; Sugawara, Shunichi; Minegishi, Yuji; Tasaka, Sadatomo; Kusumoto, Sojiro; Sakatani, Toshio; Suzuki, Hiroyuki; Hosomi, Yukio; Tambo, Yuichi; Shimokawa, Tsuneo; Ishida, Hiroo; Miyauchi, Eisaku; Naoki, Katsuhiko; Fukuhara, Tatsuro; Mura, Emiko; Tsurui, Toshiaki; Suzuki, Risako; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Manabe, Ryo; Shimokawa, Masahiro; Ohkuma, Ryotaro; Ariizumi, Hirotsugu; Kubota, Yutaro; Hamada, Kazuyuki; Takenoshita, Sachiko; Ryu, Kakei; Sambe, Takehiko; Inoue, Eisuke; Wada, Satoshi; Yoshimura, Kiyoshi; Sagara, Hironori; Kobayashi, Shinichi; Tsunoda, Takuya
NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study
MOLECULAR ONCOLOGY
IF4.5
2023-10-283
OA
Ikeda, Satoshi; Tsuboi, Masahiro; Sakai, Kazuko; Misumi, Toshihiro; Akamatsu, Hiroaki; Shoda, Hiroyasu; Sakakura, Noriaki; Nakamura, Atsushi; Ohde, Yasuhisa; Hayashi, Hidetoshi; Okishio, Kyoichi; Okada, Morihito; Yoshino, Ichiro; Okami, Jiro; Takahashi, Kazuhisa; Ikeda, Norihiko; Tanahashi, Masayuki; Tambo, Yuichi; Saito, Haruhiro; Toyooka, Shinichi; Inokawa, Hidetoshi; Chen-Yoshikawa, Toyofumi; Yokoyama, Toshihide; Okamoto, Tatsuro; Yanagitani, Noriko; Oki, Masahide; Takahama, Makoto; Sawa, Kenji; Tada, Hirohito; Nakagawa, Kazuhiko; Mitsudomi, Tetsuya; Nishio, Kazuto
Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings

在现实环境中使用免疫检查点抑制剂单药治疗的非小细胞肺癌患者的长期生存

CLINICAL LUNG CANCER
IF3.3
2022-09-0115
PRE
Yoneda, Taro; Sone, Takashi; Koba, Hayato; Shibata, Kazuhiko; Suzuki, Junya; Tani, Mayuko; Nishitsuji, Masaru; Nishi, Koichi; Kobayashi, Takafumi; Shirasaki, Hiroki; Araya, Tomoyuki; Kita, Toshiyuki; Kase, Kazumasa; Yamamura, Kenta; Terada, Nanao; Nishikawa, Shingo; Tambo, Yuichi; Kimura, Hideharu; Kasahara, Kazuo
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumors

一项开放标签，交叉研究，以比较不同的配方并评估食物对晚期实体瘤患者pimitespib药代动力学的影响

INVESTIGATIONAL NEW DRUGS
IF2.7
2022-08-063
OAAI
Komatsu, Yoshito; Shimokawa, Tsuneo; Akiyoshi, Kohei; Karayama, Masato; Shimomura, Akihiko; Kawamoto, Yasuyuki; Yuki, Satoshi; Tambo, Yuichi; Kasahara, Kazuo

研究方向

暂未获取到该数据
H
Hayato Koba
H 指数:11论文数:91被引数:776
H
Hideharu Kimura
H 指数:29论文数:187被引数:3,502
K
Kazuo Kasahara
H 指数:40论文数:443被引数:9,552
T
Takashi Sone
H 指数:22论文数:147被引数:1,785
N
Nanao Terada
H 指数:6论文数:40被引数:131
M
Makoto Nishio
H 指数:69论文数:864被引数:3.0万
T
Taro Yoneda
H 指数:10论文数:58被引数:260
N
Noriyuki Ohkura
H 指数:21论文数:132被引数:1,372
T
Tomoyuki Araya
H 指数:11论文数:73被引数:531
K
Kazumasa Kase
H 指数:4论文数:27被引数:111